Compare LMAT & WLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMAT | WLY |
|---|---|---|
| Founded | 1983 | 1807 |
| Country | United States | United States |
| Employees | N/A | 5200 |
| Industry | Medical/Dental Instruments | Books |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.1B |
| IPO Year | 2006 | N/A |
| Metric | LMAT | WLY |
|---|---|---|
| Price | $93.41 | $44.42 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $105.80 | N/A |
| AVG Volume (30 Days) | 252.6K | ★ 296.3K |
| Earning Date | 05-05-2026 | 06-16-2026 |
| Dividend Yield | 0.93% | ★ 3.50% |
| EPS Growth | ★ 30.57 | N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $249,602,000.00 | N/A |
| Revenue This Year | $14.21 | $1.04 |
| Revenue Next Year | $8.88 | $2.36 |
| P/E Ratio | $137.59 | ★ $15.84 |
| Revenue Growth | ★ 13.53 | N/A |
| 52 Week Low | $79.01 | $28.38 |
| 52 Week High | $118.01 | $45.60 |
| Indicator | LMAT | WLY |
|---|---|---|
| Relative Strength Index (RSI) | 35.69 | 65.96 |
| Support Level | $82.26 | $39.58 |
| Resistance Level | $114.38 | N/A |
| Average True Range (ATR) | 2.99 | 1.12 |
| MACD | -0.41 | 0.20 |
| Stochastic Oscillator | 27.34 | 98.20 |
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.